Patents by Inventor Richard S. Mursinna

Richard S. Mursinna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7785827
    Abstract: A method and composition for tRNA synthetases that activate and aminoacylate nonstandard and noncognate amino acids to tRNA adaptor molecules is described that can be used to generate custom designed protein products for uses in medicinal, therapeutic, diagnostic, biotechnology, engineering, and spectroscopy applications. Some tRNA synthetases naturally misactivate and misaminoacylate noncognate amino acids. Many of these tRNA synthetases, including but not limited to leucyl-, isoleucyl-, and valyl-tRNA synthetases, have evolved proofreading and editing mechanisms to correct these mistakes. Inactivation of the enzyme's editing activity allows and facilitates production and accumulation of tRNAs that are misaminoacylated with nonstandard and noncognate amino acids. These misaminoacylated tRNAs can be used to introduce novel amino acids into proteins.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: August 31, 2010
    Assignee: University of Houston System
    Inventors: Susan A. Martinis, James M. Briggs, Richard S. Mursinna, Keun Woo Lee, Tommie L. Lincecum, Amy M. Williams, Yuxin Zhai
  • Publication number: 20040203094
    Abstract: A method and composition for tRNA synthetases that activate and aminoacylate nonstandard and noncognate amino acids to tRNA adaptor molecules is described that can be used to generate custom designed protein products for uses in medicinal, therapeutic, diagnostic, biotechnology, engineering, and spectroscopy applications. Some tRNA synthetases naturally misactivate and misaminoacylate noncognate amino acids. Many of these tRNA synthetases, including but not limited to leucyl-, isoleucyl-, and valyl-tRNA synthetases, have evolved proofreading and editing mechanisms to correct these mistakes. Inactivation of the enzyme's editing activity allows and facilitates production and accumulation of tRNAs that are misaminoacylated with nonstandard and noncognate amino acids. These misaminoacylated tRNAs can be used to introduce novel amino acids into proteins.
    Type: Application
    Filed: September 20, 2002
    Publication date: October 14, 2004
    Inventors: Susan A. Martinis, James M. Briggs, Richard S. Mursinna, Keun Woo Lee, Tommie L. Lincecum, Caleb Davis, Meng Cui, Amy M. Williams, Joshua A. Speidel, Yuxin Zhai